Collaboration Details

Title of Collaborative Activity:

FNIH Advanced Medicines Partnership® - Bespoke Gene Therapy Consortium (FNIH AMP BGTC)

Description of Collaborative Activity:

Working with the Food and Drug Administration (FDA) Center for Biologics Evaluation and Research (CBER), private sector partners, and FNIH to execute AAV gene therapy research, clinical and manufacturing workstreams.

Type of Collaborative Activity:

Research Initiative

Year the Collaborative Activity Originated:

2019

NIH Participating Institutes/Centers/Office of the Director:

NCATS

HHS Agency Collaborators on this Activity:

FDA